>
Switch to:

iCo Therapeutics Non Operating Income

: $0.09 Mil (TTM As of Sep. 2020)
View and export this data going back to 2009. Start your Free Trial

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. iCo Therapeutics's non-recurring items for the three months ended in Sep. 2020 was $0.00 Mil. Its non-recurring items for the trailing twelve months (TTM) ended in Sep. 2020 was $0.09 Mil.

As of today (2021-03-02), iCo Therapeutics's share price is $0.092600. iCo Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2020 was $-0.03. Therefore, iCo Therapeutics's PE Ratio without NRI ratio for today is .

iCo Therapeutics Non Operating Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

iCo Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.11 0.18 -0.00 0.00

iCo Therapeutics Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 -0.02 0.16 -0.05 0.00

iCo Therapeutics Non Operating Income Calculation

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company's reported income drastically.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2020 was -0.018983977522971 (Dec. 2019 ) + 0.1647564469914 (Mar. 2020 ) + -0.053128689492326 (Jun. 2020 ) + 0.0022675736961451 (Sep. 2020 ) = $0.09 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

GuruFocus lists a PE Ratio without NRI, which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

iCo Therapeutics's PE Ratio without NRI Ratio for today is calculated as

PE Ratio without NRI=Share Price/EPS without NRI
=0.092600/-0.029694478430286
=

iCo Therapeutics's Share Price of today is $0.092600.
iCo Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2020 was -0.0075935910091882 (Dec. 2019 ) + -0.007163323782235 (Mar. 2020 ) + -0.0073789846517119 (Jun. 2020 ) + -0.0075585789871504 (Sep. 2020 ) = $-0.03.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

iCo Therapeutics Non Operating Income Related Terms

iCo Therapeutics Non Operating Income Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)